ArticleBBA advances2026

CEMIP promotes gefitinib resistance in lung cancer with EGFR-mutation possibly through forming a stable complex CEMIP/c-MYC.

Li Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.